Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$268K Buy
6,253
+123
+2% +$5.29K 0.01% 225
2025
Q4
$269K Buy
+6,130
New +$254K 0.01% 223

Other funds holding EXEL

GenTrust's EXEL Position: Q1 2026 in Review

GenTrust increased its Exelixis (EXEL) stake by 2% in Q1 2026, buying an estimated $5.29K and bringing the position to 6,253 shares worth $268K. The position accounts for 0.01% of the portfolio, ranked #225.

GenTrust first reported a position in EXEL in Q4 2025 and has held it in 2 quarters since. The position peaked at $269K in Q4 2025. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • GenTrust held 6,253 shares of Exelixis worth $268K as of Q1 2026.
  • GenTrust bought 123 Exelixis shares in Q1 2026, an estimated $5.29K.
  • Exelixis made up 0.01% of GenTrust's portfolio in Q1 2026, its #225 holding.
  • GenTrust first reported a position in Exelixis in Q4 2025 and has held it in 2 quarters since.
  • GenTrust's Exelixis position peaked at $269K in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on GenTrust's 13F filing for Q1 2026, filed 27 Apr 2026.